These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 25262924
1. Haemovigilance data on the use of methylene blue virally inactivated fresh frozen plasma with the Theraflex MB-Plasma System in comparison to quarantine plasma: 11 years' experience. Politis C, Kavallierou L, Hantziara S, Parara M, Zervou E, Katsarou O, Hatzitaki M, Fountouli P, Gioka A, Tzioura K, Koumarianos S, Asariotou M, Richardson C. Transfus Med; 2014 Oct; 24(5):316-20. PubMed ID: 25262924 [Abstract] [Full Text] [Related]
3. A regional haemovigilance retrospective study of four types of therapeutic plasma in a ten-year survey period in France. Bost V, Odent-Malaure H, Chavarin P, Benamara H, Fabrigli P, Garraud O. Vox Sang; 2013 May; 104(4):337-41. PubMed ID: 23294315 [Abstract] [Full Text] [Related]
4. Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience. Politis C, Kavallierou L, Hantziara S, Katsea P, Triantaphylou V, Richardson C, Tsoutsos D, Anagnostopoulos N, Gorgolidis G, Ziroyannis P. Vox Sang; 2007 May; 92(4):319-26. PubMed ID: 17456156 [Abstract] [Full Text] [Related]
5. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Osselaer JC, Debry C, Goffaux M, Pineau J, Calomme G, Dubuc E, Chatelain B, Vandendaele MC, Hsu J, Rheinschmidt M, Lin L. Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283 [Abstract] [Full Text] [Related]
6. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products. Steinmann E, Gravemann U, Friesland M, Doerrbecker J, Müller TH, Pietschmann T, Seltsam A. Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868 [Abstract] [Full Text] [Related]
7. Transmission of human immunodeficiency virus Type-1 by fresh-frozen plasma treated with methylene blue and light. Álvarez M, Luis-Hidalgo M, Bracho MA, Blanquer A, Larrea L, Villalba J, Puig N, Planelles D, Montoro J, González-Candelas F, Roig R. Transfusion; 2016 Apr; 56(4):831-6. PubMed ID: 26585542 [Abstract] [Full Text] [Related]
8. [Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy]. Lepri D, Capuzzo E, Mattioli AV, Dall'Oglio D, Sgarioto V, Terenziani I, Caramaschi G, Manzato F, Franchini M. Recenti Prog Med; 2013 Mar; 104(3):106-11. PubMed ID: 23548954 [Abstract] [Full Text] [Related]
9. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology. Reichenberg S, Gravemann U, Sumian C, Seltsam A. Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343 [Abstract] [Full Text] [Related]
10. Paired comparison of methylene blue- and amotosalen-treated plasma and cryoprecipitate. Backholer L, Wiltshire M, Proffitt S, Cookson P, Cardigan R. Vox Sang; 2016 May; 110(4):352-61. PubMed ID: 26757252 [Abstract] [Full Text] [Related]
11. Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivation. Thiele T, Kellner S, Hron G, Wasner C, Nauck M, Zimmermann K, Wessel A, Warkentin TE, Greinacher A, Selleng K. Transfusion; 2012 Mar; 52(3):529-36. PubMed ID: 21880044 [Abstract] [Full Text] [Related]
12. Update on pathogen reduction technology for therapeutic plasma: an overview. Solheim BG, Seghatchian J. Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528 [Abstract] [Full Text] [Related]
13. West Nile virus in plasma is highly sensitive to methylene blue-light treatment. Mohr H, Knüver-Hopf J, Gravemann U, Redecker-Klein A, Müller TH. Transfusion; 2004 Jun; 44(6):886-90. PubMed ID: 15157256 [Abstract] [Full Text] [Related]
14. Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers. Chunhui Y, Guohui B, Hong Y, Xiaopu X, Zherong B, Mingyuan W, Xinsheng Z, Juanjuan W, Changqing L, Wuping L. Transfus Apher Sci; 2013 Dec; 49(3):631-9. PubMed ID: 23928128 [Abstract] [Full Text] [Related]
15. [Initial experiences with methylene blue virus inactivated fresh frozen plasma: results of a clinical and in vitro study]. Wieding JU, Neumeyer H. Infusionsther Transfusionsmed; 1992 Apr; 19(2):84-90. PubMed ID: 1623325 [Abstract] [Full Text] [Related]
16. Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Alvarez-Larrán A, Del Río J, Ramírez C, Albo C, Peña F, Campos A, Cid J, Muncunill J, Sastre JL, Sanz C, Pereira A. Vox Sang; 2004 May; 86(4):246-51. PubMed ID: 15144529 [Abstract] [Full Text] [Related]
17. Online reporting system for transfusion-related adverse events to enhance recipient haemovigilance in Japan: a pilot study. Odaka C, Kato H, Otsubo H, Takamoto S, Okada Y, Taneichi M, Okuma K, Sagawa K, Hoshi Y, Tasaki T, Fujii Y, Yonemura Y, Iwao N, Tanaka A, Okazaki H, Momose SY, Kitazawa J, Mori H, Matsushita A, Nomura H, Yasoshima H, Ohkusa Y, Yamaguchi K, Hamaguchi I. Transfus Apher Sci; 2013 Feb; 48(1):95-102. PubMed ID: 22954634 [Abstract] [Full Text] [Related]
18. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma. Zeiler T, Riess H, Wittmann G, Hintz G, Zimmermann R, Müller C, Heuft HG, Huhn D. Transfusion; 1994 Aug; 34(8):685-9. PubMed ID: 8073485 [Abstract] [Full Text] [Related]
19. Anaphylactic reaction after methylene blue-treated plasma transfusion. Dewachter P, Castro S, Nicaise-Roland P, Chollet-Martin S, Le Beller C, Lillo-le-Louet A, Mouton-Faivre C. Br J Anaesth; 2011 May; 106(5):687-9. PubMed ID: 21310720 [Abstract] [Full Text] [Related]